Hypertriglyceridemia is linked to reduced nitric oxide synthesis in women with hypertensive disorders of pregnancy

Hypertension in Pregnancy

Volumn 26, Issue 4, 2007, Pages 423-431

  Mayret Mesquiti, Mayi ^a   Pérez Méndez, Oscar ^b   Rodríguez, Maria Elena ^a   Fortoul, Teresa I ^c   Gorocica, Patrícia ^d   Bernal Alcántara, Demetrio ^d   Montaño, Luis Felipe ^e   Alvarado Vasquez, Noé ^d  

^a HOSPITAL REGIONAL LIC ADOLFO LÓPEZ MATEOS   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Metabolic syndrome; Nitric oxide; Preeclampsia; Triglycerides; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; MATERNAL HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREECLAMPSIA; PREGNANT WOMAN; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; HYPERTRIGLYCERIDEMIA; NITRIC OXIDE; NITRITES; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; TRIGLYCERIDES;

EID: 36849055642     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701521569     Document Type: Article

References (34)

1. Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, Giles WH, Kittner SJ. Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke 2006; 37:1055-1059.
2. Ferrer Arreola L, Basavilvazo Rodriguez MA, Lemus Rocha R, Toca Porraz L, Hernandez Valencia M. Analysis of trends in maternal mortality during a 10-year follow up in a urban region. Ginecol Obstet Mex 2005;73:477-483.
3. Romero-Gutierrez G, Malacara JM, Amador N, Fierro-Martinez C, Munoz-Guevara LM, Molina-Rodriguez R. Homeostatic model assessment and risk for hypertension during pregnancy: a longitudinal prospective study. Am J Perinatol 2004; 21:455-462.
4. Dekker GA, Robillard PY. Preeclampsia: a couple's disease with maternal and fetal manifestations. Curr Pharm Des 2005;11:699-710.
5. Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Vanninen E, Heinonen S. Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J 2006;70:768-772.
6. Bayhan G, Kocyigit Y, Atamer A, Atamer Y, Akkus Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol 2005;21:1-6.
7. Vadachkoria S, Woelk GB, Mahomed K, Qiu C, Muy-Rivera M, Malinow MR, Williams MA. Elevated soluble vascular cell adhesion molecule-1, elevated Homocyst(e)inemia, and hypertriglyceridemia in relation to preeclampsia risk. Am J Hypertens 2006;19:235-242.
8. Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006;113:379-386.
9. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004;17:574-581.
10. Ranta V, Viinikka L, Halmesmaki E, Ylikorkala O. Nitric oxide production with preeclampsia. Obstet Gynecol 1999;93:442-445.
11. Diejomaoh FM, Omu AE, Al-Busiri N, Taher S, Al-Othman S, Fatinikun T, Fernandes S. Nitric oxide production is not altered in preeclampsia. Arch Gynecol Obstet 2004;269:237-243.
12. Wang Y, Gu Y, Zhang Y, Lewis DF. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol 2004;190:817-824.
13. Choi JW, Im MW, Pai SH. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002;32:257-263.
14. Qiu C, Williams MA, Leisenring WM, Sorensen TK, Frederick IO, Dempsey JC, Luthy DA. Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension 2003 Mar;41:408-413.
15. Kaaja RJ, Greer IA: Manifestations of chronic disease during pregnancy. JAMA 2005;294:2751-2757.
16. DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 1986; 256:2372-2377.
17. Nisell H. Is carbohydrate metabolism altered among women who have undergone a preeclamptic pregnancy?. Gynecol Obstet Invest 1999;48:44-48.
18. Innes, KE. Altered metabolic profiles among older mothers with a history of preeclampsia. Gynecol Obstet Invest 2005;59:192-201.
19. Rowe J, Campbell S, Gallery ED. Nitric oxide production by decidual endothelial cells is not reduced in preeclampsia. Hypertens Pregnancy 2003;22:63-75.
20. Mutlu-Turkoglu U, Aykac-Toker G, Ibrahimoglu L, Ademoglu E, Uysal M. Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecol Obstet Invest 1999;48:247-250.
21. Solomon CG, Seely EW. Brief review: hypertension in pregnancy: A manifestation of the insulin resistance syndrome? Hypertension 2001;37:232-239.
22. Ma RM, Lao TT. Maternal mean arterial pressure and oral glucose tolerance test results. Relationship in normotensive women. J Reprod Med 2001;46:747-751.
23. Barden A, Singh R, Walters BN, Ritchie J, Roberman B, Beilin LJ. Factors predisposing to pre-eclampsia in women with gestational diabetes. J Hypertens 2004;22:2371-2378.
24. Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006;30:1164-1170.
25. Martin A, O'Sullivan AJ, Brown MA. Body composition and energy metabolism in normotensive and hypertensive pregnancy. BJOG 2001;108:1263-1271.
26. Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe preeclampsia related to pre-existing conditions. Intl J Epidemiol 2007;36:412-419.
27. Erez-Weiss I, Erez O, Shoham-Vardi I, Holcberg G, Mazor M. The association between maternal obesity, glucose intolerance and hypertensive disorders of pregnancy in nondiabetic pregnant women. Hypertens Pregnancy 2005;24:125-136.
28. Kompoti M, Mariolis A, Alevizos A, Kyrazis I, Protopsaltis I, Dimou E, Lentzas I, Levisianou D, Gova A, Melidonis A. Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes. Cardiovasc Diabetol 2006;4:5-21.
29. Forest JC, Girouard J, Masse J, Moutquin JM, Kharfi A, Ness RB, Roberts JM, Giguere Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005;105:1373-1380.
30. Cohn GS, Kittleson MM, Blumenthal RS. Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance. Am J Hypertens 2005;18:1099-1103.
31. Marchesi S, Lupattelli G, Siepi D, Roscini AR, Vaudo G, Sinzinger H, Mannarino E. Oral L-arginine administration attenuates postprandial endothelial dysfunction in young healthy males. J Clin Pharm Ther 2001;26:343-349.
32. Reynolds SS, Yanek LR, Vaidya D, Mora S, Moy TF, Saudek CD, Becker LC, Becker DM. Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease. Diabetes Res Clin Pract 2006;74:267-273.
33. Roes EM, Sieben R, Raijmakers MT, Peters WH, Steegers EA. Severe preeclampsia is associated with a positive family history of hypertension and hypercholesterolemia. Hypertens Pregnancy 2005;24:259-271.
34. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565.